JOINT FILING AGREEMENT
Exhibit 99.5
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value £0.01 per share, of Summit Therapeutics PLC, a foreign private issuer incorporated in England and Wales. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
|
/s/ Xxxxxx Xxxxxxxx | |||
| Xxxxxx Xxxxxxxx | |||
| XXXXXX XXXXXXXX REVOCABLE TRUST | |||
| XXXXX XXXXXXXX IRREVOCABLE TRUST | |||
| By: |
/s/ Xxxxxx Xxxxxxxx | ||
| Name: | Xxxxxx Xxxxxxxx | ||
| Title: | Trustee | ||
